Schrodinger raises $232M in IPO

15:41 EST 11 Feb 2020 | MedCity News

Drug discovery software company Schrödinger raised $232 million in its IPO, which closed Monday. The company’s stock was trading at $27.22 on Tuesday.

Original Article: Schrodinger raises $232M in IPO


More From BioPortfolio on "Schrodinger raises $232M in IPO"

Quick Search

Relevant Topic

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...